Best TWAS P=2.61e-35 · Best GWAS P=2.45e-60 conditioned to 1.71e-27
# | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | GTEx | Artery Tibial | RP11-446E9.1 | 0.07 | 0.00 | lasso | 6 | 0.00 | 6.6e-01 | -7.5 | 8.9 | 7.0e-19 | -0.76 | 0.02 | 0.75 | FALSE |
2 | GTEx | Brain Cerebellum | RPS20 | 0.26 | 0.07 | enet | 17 | 0.10 | 5.4e-04 | -10.7 | -9.7 | 4.1e-22 | 0.60 | 0.30 | 0.23 | FALSE |
3 | GTEx | Brain Cerebellum | RP11-446E9.1 | 0.15 | 0.05 | lasso | 3 | 0.03 | 3.7e-02 | -7.6 | 7.4 | 1.6e-13 | -0.53 | 0.05 | 0.55 | FALSE |
4 | GTEx | Brain Nucleus accumbens basal ganglia | RPS20 | 0.41 | 0.05 | lasso | 8 | 0.13 | 3.1e-04 | -8.0 | -7.5 | 5.5e-14 | 0.53 | 0.05 | 0.23 | FALSE |
5 | GTEx | Cells EBV-transformed lymphocytes | LYN | 0.35 | 0.07 | enet | 37 | 0.17 | 4.5e-06 | 11.6 | -5.7 | 1.3e-08 | -0.07 | 0.15 | 0.04 | FALSE |
6 | GTEx | Esophagus Muscularis | RPS20 | 0.12 | 0.04 | lasso | 6 | 0.05 | 7.2e-04 | -10.8 | -10.6 | 2.6e-26 | 0.76 | 0.22 | 0.65 | FALSE |
7 | GTEx | Muscle Skeletal | RPS20 | 0.07 | 0.09 | lasso | 1 | 0.07 | 1.5e-07 | -7.5 | -7.5 | 7.2e-14 | 0.49 | 0.99 | 0.01 | FALSE |
8 | GTEx | Skin Not Sun Exposed Suprapubic | RPS20 | 0.18 | 0.03 | enet | 12 | 0.07 | 1.5e-04 | -10.3 | -12.4 | 2.6e-35 | 0.81 | 0.11 | 0.60 | TRUE |
9 | GTEx | Stomach | RP11-446E9.1 | 0.12 | 0.08 | lasso | 4 | 0.03 | 1.7e-02 | -6.8 | 6.8 | 1.5e-11 | -0.48 | 0.30 | 0.08 | FALSE |
10 | ROSMAP | Brain Pre-frontal Cortex | RPS20 | 0.24 | 0.20 | lasso | 6 | 0.23 | 3.4e-29 | -9.3 | -8.3 | 7.6e-17 | 0.51 | 1.00 | 0.00 | FALSE |
11 | ROSMAP | Brain Pre-frontal Cortex | RP11-446E9.1 | 0.23 | 0.32 | lasso | 7 | 0.34 | 2.0e-45 | -7.5 | 8.6 | 1.2e-17 | -0.53 | 1.00 | 0.00 | FALSE |
12 | The Cancer Genome Atlas | Bladder Urothelial Carcinoma | PENK | 0.03 | 0.01 | blup | 40 | 0.03 | 9.1e-04 | -5.5 | -6.0 | 1.5e-09 | -0.01 | 0.02 | 0.77 | TRUE |
13 | The Cancer Genome Atlas | Breast Invasive Carcinoma | PENK | 0.03 | 0.04 | enet | 7 | 0.05 | 6.2e-10 | 4.9 | -5.7 | 1.2e-08 | -0.06 | 0.16 | 0.83 | FALSE |
14 | The Cancer Genome Atlas | Colon Adenocarcinoma | PENK | 0.11 | 0.13 | lasso | 2 | 0.14 | 2.6e-08 | -5.8 | -6.0 | 2.3e-09 | 0.06 | 0.01 | 0.99 | FALSE |
15 | The Cancer Genome Atlas | Esophageal Carcinoma | PENK | 0.35 | 0.21 | enet | 12 | 0.33 | 3.8e-11 | 5.1 | -5.7 | 1.1e-08 | -0.02 | 0.04 | 0.96 | FALSE |
16 | The Cancer Genome Atlas | Head and Neck Squamous Cell Carcinoma | PENK | 0.07 | 0.06 | enet | 8 | 0.08 | 2.4e-09 | -5.3 | -6.0 | 1.6e-09 | 0.04 | 0.02 | 0.98 | FALSE |
17 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | RPS20 | 0.04 | 0.02 | blup | 29 | 0.03 | 4.8e-04 | -9.1 | -8.2 | 3.8e-16 | 0.49 | 0.03 | 0.03 | FALSE |
18 | The Cancer Genome Atlas | Brain Lower Grade Glioma | RPS20 | 0.33 | 0.07 | enet | 8 | 0.07 | 1.7e-08 | -9.3 | -10.5 | 1.2e-25 | 0.49 | 0.96 | 0.03 | FALSE |
19 | The Cancer Genome Atlas | Pancreatic Adenocarcinoma | PENK | 0.23 | 0.15 | lasso | 5 | 0.22 | 8.2e-10 | 4.8 | -5.7 | 1.6e-08 | -0.02 | 0.04 | 0.96 | FALSE |
20 | The Cancer Genome Atlas | Prostate Adenocarcinoma | RPS20 | 0.04 | 0.03 | lasso | 3 | 0.04 | 1.3e-04 | -9.3 | -9.2 | 2.4e-20 | 0.58 | 0.15 | 0.05 | FALSE |
21 | The Cancer Genome Atlas | Rectum Adenocarcinoma | PENK | 0.18 | 0.11 | lasso | 1 | 0.09 | 3.4e-03 | -5.8 | -5.8 | 8.9e-09 | 0.08 | 0.01 | 0.67 | FALSE |
22 | The Cancer Genome Atlas | Stomach Adenocarcinoma | PENK | 0.07 | 0.08 | lasso | 2 | 0.06 | 2.0e-05 | -5.3 | -5.3 | 1.2e-07 | 0.11 | 0.02 | 0.98 | FALSE |
23 | The Cancer Genome Atlas | Thyroid Carcinoma | LYN | 0.09 | 0.12 | lasso | 2 | 0.12 | 8.4e-12 | -6.8 | 6.9 | 4.1e-12 | -0.49 | 1.00 | 0.00 | FALSE |